文献速递慢性肾脏病

肾功能与高密度脂蛋白蛋白质组成改变相关

Kidney function is associated with an altered protein composition of high-density lipoprotein.
PubMed 文献 · Kidney Int · 2017-07-26

在509例CKD患者中,采用靶向质谱定量HDL颗粒内38种蛋白质,发现eGFR与4种HDL蛋白水平独立相关;eGFR<15相比≥60者,RBP4和ApoC-III升高,ApoL1和玻连蛋白降低,提示HDL蛋白质组与肾功能下降相关。

要点

  • CKD患者HDL蛋白质组成随eGFR下降而改变。
  • eGFR<15者HDL中RBP4和ApoC-III升高、ApoL1和玻连蛋白降低。
  • HDL蛋白质组变化与肾功能关联需进一步验证。

核心结论

  • 肾功能下降与HDL颗粒中4种蛋白质含量改变独立相关,为HDL蛋白质组与肾功能关联提供初步证据。

研究设计与样本

  • 靶向质谱定量HDL颗粒内38种蛋白质,纳入509例CKD队列,eGFR覆盖CKD I-V期,平均eGFR 45.5 mL/min/1.73m2。

主要发现

  • 校正多重检验、人口学、合并症、药物等因素后,eGFR与4种HDL蛋白差异显著相关。
  • eGFR<15相比≥60者,RBP4高1.89倍(95%CI 1.34-2.67),ApoC-III高1.52倍(1.25-1.84)。
  • eGFR<15相比≥60者,ApoL1低0.70倍(0.55-0.92),玻连蛋白低0.64倍(0.48-0.85)。
  • HDL中ApoL1在非裔美国人略低于白人,但与eGFR的关系无种族差异。
  • 校正后,HDL相关蛋白与白蛋白尿无显著关联。

临床怎么用

  • 目前HDL蛋白质组改变仅提示与肾功能下降相关,尚不能作为临床预测指标。

局限性

  • 结果为初步证据,需重复验证。
  • HDL蛋白质组能否预测肾功能下降或心血管结局尚待未来分析确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with chronic kidney disease (CKD) exhibit a myriad of metabolic derangements, including dyslipidemia characterized by low plasma concentrations of high-density lipoprotein (HDL)-associated cholesterol. However, the effects of kidney disease on HDL composition have not been comprehensively determined. Here we used a targeted mass spectrometric approach to quantify 38 proteins contained in the HDL particles within a CKD cohort of 509 participants with a broad range of estimated glomerular filtration rates (eGFRs) (CKD stages I-V, and a mean eGFR of 45.5 mL/min/1.73m2). After adjusting for multiple testing, demographics, comorbidities, medications, and other characteristics, eGFR was significantly associated with differences in four HDL proteins. Compared to participants with an eGFR of 60 mL/min/1.73m2 or more, those with an eGFR under 15 mL/min/1.73m2 exhibited 1.89-fold higher retinol-binding protein 4 (95% confidence interval 1.34-2.67), 1.52-fold higher apolipoprotein C-III (1.25-1.84), 0.70-fold lower apolipoprotein L1 (0.55-0.92), and 0.64-fold lower vitronectin (0.48-0.85). Although the HDL apolipoprotein L1 was slightly lower among African Americans than among Caucasian individuals, the relationship to eGFR did not differ by race. After adjustment, no HDL-associated proteins associated with albuminuria. Thus, modest changes in the HDL proteome provide preliminary evidence for an association between HDL proteins and declining kidney function, but this needs to be replicated. Future analyses will determine if HDL proteomics is indeed a clinical predictor of declining kidney function or cardiovascular outcomes.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Rubinow KB, Henderson CM, Robinson-Cohen C, et al. Kidney function is associated with an altered protein composition of high-density lipoprotein. Kidney Int. 2017. PMID: 28754556. doi:10.1016/j.kint.2017.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。